JPMorgan raised the firm’s price target on Leidos to $185 from $175 and keeps an Overweight rating on the shares. The company retains momentum but the shares offer less upside following the strong year-to-date performance, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LDOS:
- Leidos price target raised to $183 from $172 at Wells Fargo
- Leidos oins Lunar Dawn team to collaborate on human-rated Moon rover
- Leidos Holdings Welcomes Tina W. Jonas to Expanded Board
- Leidos price target raised to $175 from $165 at Truist
- Leidos awarded CDC’s National Health Safety Network modernization contract